Annual Working Capital
$197.54 M
-$190.09 M-49.04%
December 31, 2023
Summary
- As of February 7, 2025, IOVA annual working capital is $197.54 million, with the most recent change of -$190.09 million (-49.04%) on December 31, 2023.
- During the last 3 years, IOVA annual working capital has fallen by -$383.69 million (-66.01%).
- IOVA annual working capital is now -66.01% below its all-time high of $581.23 million, reached on December 31, 2020.
Performance
IOVA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$380.52 M
-$8.10 M-2.08%
September 30, 2024
Summary
- As of February 7, 2025, IOVA quarterly working capital is $380.52 million, with the most recent change of -$8.10 million (-2.08%) on September 30, 2024.
- Over the past year, IOVA quarterly working capital has increased by +$78.20 million (+25.87%).
- IOVA quarterly working capital is now -47.71% below its all-time high of $727.75 million, reached on June 30, 2020.
Performance
IOVA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IOVA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.0% | +25.9% |
| 3 y3 years | -66.0% | +3.6% |
| 5 y5 years | -57.1% | +3.6% |
IOVA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.8% | at low | -30.9% | +104.3% |
| 5 y | 5-year | -66.0% | at low | -47.7% | +104.3% |
| alltime | all time | -66.0% | +1640.3% | -47.7% | +2299.4% |
Iovance Biotherapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $380.52 M(-2.1%) |
| Jun 2024 | - | $388.62 M(+28.5%) |
| Mar 2024 | - | $302.32 M(+53.0%) |
| Dec 2023 | $197.54 M(-49.0%) | $197.54 M(-32.3%) |
| Sep 2023 | - | $291.63 M(+56.6%) |
| Jun 2023 | - | $186.24 M(-66.2%) |
| Mar 2023 | - | $550.51 M(+42.0%) |
| Dec 2022 | $387.63 M(-7.4%) | $387.63 M(+33.4%) |
| Sep 2022 | - | $290.64 M(-20.9%) |
| Jun 2022 | - | $367.40 M(-11.0%) |
| Mar 2022 | - | $412.89 M(-1.4%) |
| Dec 2021 | $418.76 M(-28.0%) | $418.76 M(-19.2%) |
| Sep 2021 | - | $518.26 M(-14.5%) |
| Jun 2021 | - | $606.11 M(+10.2%) |
| Mar 2021 | - | $550.16 M(-5.3%) |
| Dec 2020 | $581.23 M(+109.5%) | $581.23 M(-11.8%) |
| Sep 2020 | - | $659.20 M(-9.4%) |
| Jun 2020 | - | $727.75 M(+235.6%) |
| Mar 2020 | - | $216.84 M(-21.8%) |
| Dec 2019 | $277.41 M(-39.8%) | $277.41 M(-16.6%) |
| Sep 2019 | - | $332.69 M(-11.8%) |
| Jun 2019 | - | $377.10 M(-10.8%) |
| Mar 2019 | - | $422.62 M(-8.3%) |
| Dec 2018 | $460.98 M(+230.0%) | $460.98 M(+85.0%) |
| Sep 2018 | - | $249.19 M(-6.2%) |
| Jun 2018 | - | $265.60 M(-7.8%) |
| Mar 2018 | - | $288.04 M(+106.2%) |
| Dec 2017 | $139.69 M(-15.1%) | $139.69 M(-14.2%) |
| Sep 2017 | - | $162.85 M(+28.7%) |
| Jun 2017 | - | $126.57 M(-13.9%) |
| Mar 2017 | - | $147.09 M(-10.6%) |
| Dec 2016 | $164.54 M | $164.54 M(-7.2%) |
| Sep 2016 | - | $177.36 M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $187.74 M(+92.5%) |
| Mar 2016 | - | $97.53 M(-4.7%) |
| Dec 2015 | $102.35 M(+136.3%) | $102.35 M(-4.8%) |
| Sep 2015 | - | $107.54 M(-3.0%) |
| Jun 2015 | - | $110.85 M(+1.2%) |
| Mar 2015 | - | $109.50 M(+152.8%) |
| Dec 2014 | $43.31 M(+146.4%) | $43.31 M(+171.2%) |
| Sep 2014 | - | $15.97 M(-8.0%) |
| Jun 2014 | - | $17.36 M(+2.4%) |
| Mar 2014 | - | $16.96 M(-3.5%) |
| Dec 2013 | $17.58 M(-255.0%) | $17.58 M(-621.5%) |
| Sep 2013 | - | -$3.37 M(+20.8%) |
| Jun 2013 | - | -$2.79 M(-77.3%) |
| Mar 2013 | - | -$12.30 M(+8.4%) |
| Dec 2012 | -$11.34 M(-11.6%) | -$11.34 M(-31.7%) |
| Sep 2012 | - | -$16.61 M(-0.3%) |
| Jun 2012 | - | -$16.66 M(-3.7%) |
| Mar 2012 | - | -$17.30 M(+34.9%) |
| Dec 2011 | -$12.83 M(-2783.1%) | -$12.83 M(+119.9%) |
| Sep 2011 | - | -$5.83 M(+277.7%) |
| Jun 2011 | - | -$1.54 M(-9076.7%) |
| Mar 2011 | - | $17.20 K(-96.4%) |
| Dec 2010 | $478.00 K(-3351.7%) | $478.00 K(+108.8%) |
| Sep 2010 | - | $228.90 K(+15.3%) |
| Jun 2010 | - | $198.60 K(-29.5%) |
| Mar 2010 | - | $281.70 K(-2016.3%) |
| Dec 2009 | -$14.70 K(+7250.0%) | -$14.70 K(+15.7%) |
| Sep 2009 | - | -$12.70 K(+33.7%) |
| Jun 2009 | - | -$9500.00(+43.9%) |
| Mar 2009 | - | -$6600.00(+3200.0%) |
| Dec 2008 | -$200.00 | -$200.00(-101.5%) |
| Sep 2008 | - | $13.70 K(-13.8%) |
| Jun 2008 | - | $15.90 K(-48.0%) |
| Mar 2008 | - | $30.60 K |
FAQ
- What is Iovance Biotherapeutics annual working capital?
- What is the all time high annual working capital for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual working capital year-on-year change?
- What is Iovance Biotherapeutics quarterly working capital?
- What is the all time high quarterly working capital for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly working capital year-on-year change?
What is Iovance Biotherapeutics annual working capital?
The current annual working capital of IOVA is $197.54 M
What is the all time high annual working capital for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual working capital is $581.23 M
What is Iovance Biotherapeutics annual working capital year-on-year change?
Over the past year, IOVA annual working capital has changed by -$190.09 M (-49.04%)
What is Iovance Biotherapeutics quarterly working capital?
The current quarterly working capital of IOVA is $380.52 M
What is the all time high quarterly working capital for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly working capital is $727.75 M
What is Iovance Biotherapeutics quarterly working capital year-on-year change?
Over the past year, IOVA quarterly working capital has changed by +$78.20 M (+25.87%)